Author

Edwin F. Ortega

University of California, San Francisco

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Systems Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1 Assay:metagenomics· 1 Organism:mouse· 1 Approach:statistical model· 1

Frequent Co-Authors

Alan Paul VenookiD· 1 shared Benjamin G. H. Guthrie· 1 shared C. Anders OlsoniD· 1 shared Cecilia A. NoeckeriD· 1 shared Chloe Evelyn AtreyaiD· 1 shared Dalila Stanfield· 1 shared Darren S. DumlaoiD· 1 shared Erin L. Van BlariganiD· 1 shared

Activity by Year

2024-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperSystems Biology

Alan Paul VenookORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Expansion of a bacterial operon during cancer treatment ameliorates drug toxicity

Kai R. Trepka, Wesley Allen Kidder, Than S. Kyaw, Taylor Halsey, C. Anders Olson, Edwin F. Ortega, Cecilia A. Noecker, Vaibhav Upadhyay, Dalila Stanfield, Paige Steiding, Benjamin G. H. Guthrie, Peter Spanogiannopoulos, Darren S. Dumlao, Jessie A. Turnbaugh, Matthew D. Stachler, , Peter James Turnbaugh

The paper shows that a bacterial operon in the gut microbiome can reduce drug toxicity during cancer treatment by inactivating 5-fluorouracil.

bioRxiv · Jun 4, 2024 · PreprintSystems Biology